BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32772829)

  • 21. Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation.
    Odate T; Oishi N; Kawai M; Tahara I; Mochizuki K; Akaishi J; Ito K; Katoh R; Kondo T
    Endocr Pathol; 2021 Sep; 32(3):347-356. PubMed ID: 33761111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.
    De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
    Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mTOR Kinase Inhibitor CZ415 Inhibits Human Papillary Thyroid Carcinoma Cell Growth.
    Li X; Li Z; Song Y; Liu W; Liu Z
    Cell Physiol Biochem; 2018; 46(2):579-590. PubMed ID: 29617677
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Tanaka A; Matsuse M; Saenko V; Nakao T; Yamanouchi K; Sakimura C; Yano H; Nishihara E; Hirokawa M; Suzuki K; Miyauchi A; Eguchi S; Yoshiura KI; Yamashita S; Nagayasu T; Mitsutake N
    Thyroid; 2019 Aug; 29(8):1105-1114. PubMed ID: 31286848
    [No Abstract]   [Full Text] [Related]  

  • 25. TFE3 Regulates the Function of the Autophagy-Lysosome Pathway to Drive the Invasion and Metastasis of Papillary Thyroid Carcinoma.
    Lu H; Zhu C; Ruan Y; Fan L; Wei K; Yang Z; Chen Q
    Anal Cell Pathol (Amst); 2021; 2021():3081491. PubMed ID: 34660181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
    Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERT alleviates irradiation-induced late rectal injury by reducing hypoxia-induced ROS levels through the activation of NF-κB and autophagy.
    Liu Q; Sun Y; Lv Y; Le Z; Xin Y; Zhang P; Liu Y
    Int J Mol Med; 2016 Sep; 38(3):785-93. PubMed ID: 27431814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
    Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
    World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A-mediated fatty acid oxidative pathway.
    Liang Z; He H; Zhang B; Kai Z; Zong L
    Drug Dev Res; 2024 Apr; 85(2):e22168. PubMed ID: 38450796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIF-1α and HSP90: target molecules selected from a tumorigenic papillary thyroid carcinoma cell line.
    Mo JH; Choi IJ; Jeong WJ; Jeon EH; Ahn SH
    Cancer Sci; 2012 Mar; 103(3):464-71. PubMed ID: 22151618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
    Lin X; Su H; Huo J; Zhang F
    Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockout of ASAP1 induces autophagy in papillary thyroid carcinoma by inhibiting the mTOR signaling pathway.
    Jiang N; Yang Y; Zhao G; Yuan Q; Liu Z; Wang X; Geng Z; Jia M; Zheng J; Lu X; Yue J; Fan Y
    Pathol Res Pract; 2020 Jun; 216(6):152950. PubMed ID: 32307199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
    Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
    Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
    Yeh YH; Hsiao HF; Yeh YC; Chen TW; Li TK
    J Exp Clin Cancer Res; 2018 Mar; 37(1):70. PubMed ID: 29587825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
    Zhang J; Han L; Yu J; Li H; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
    Kim MH; Ko SH; Bae JS; Lee SH; Jung CK; Lim DJ; Baek KH; Kim SH; Lee JM; Kang MI; Cha BY
    Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.
    Wang F; Zhang J; Zhou G
    Arch Oral Biol; 2019 Feb; 98():26-31. PubMed ID: 30419486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
    Chien MN; Yang PS; Hsu YC; Liu TP; Lee JJ; Cheng SP
    Head Neck; 2018 Nov; 40(11):2528-2537. PubMed ID: 30102829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.